{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:09:42Z","timestamp":1745388582160},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.2169\/internalmedicine.4226-19","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T22:04:38Z","timestamp":1587593078000},"page":"1887-1890","source":"Crossref","is-referenced-by-count":3,"title":["Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome as an Initial Manifestation"],"prefix":"10.2169","volume":"59","author":[{"given":"Tomoaki","family":"Shima","sequence":"first","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Tsujino","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kairi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kanamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Nagaoka","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiichiro","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tsujino","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202: 473-477, 2005.","DOI":"10.1084\/jem.20050304"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Wingerchuk DM, Banwell B, Bennett JL, et al. International panel for NMO diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85: 177-189, 2015.","DOI":"10.1212\/WNL.0000000000001729"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28: 1320-1327, 2007.","DOI":"10.3174\/ajnr.A0549"},{"key":"4","unstructured":"4. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85: 427-432, 2010."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Karia SJ, Rykken JB, McKinney ZJ, Zhang L, McKinney AM. Utility and significance of gadolinium-based contrast enhancement in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 37: 415-422, 2016.","DOI":"10.3174\/ajnr.A4563"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Maga\u00f1a SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72: 712-717, 2009.","DOI":"10.1212\/01.wnl.0000343001.36493.ae"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shimazaki H, Ando A, Nakamura Y, Kanbayashi T, Tanaka K, Nakano I. A case of neuromyelitis optica complicated by posterior reversible encephalopathy syndrome and a papillary thyroid cancer. Nihon Naika Gakkai Zasshi (Journal of Japanese Society of Internal Medicine) 99: 1913-1915, 2010 (in Japanese).","DOI":"10.2169\/naika.99.1913"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Igel C, Garretto D, Robbins MS, Swerdlow M, Judge N, Dayal A. Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death. J Clin Med Res 7: 193-195, 2015.","DOI":"10.14740\/jocmr2031w"},{"key":"9","unstructured":"9. Benmoh Y, Hamid M, Arrami A, et al. Neuromyelitis optica spectrum disorders associated to posterior reversible encephalopathy syndrome: pathogenesis, dignosis, treatment and evolution: a case report and literature review. J Neurol Neurophysiol 9: 472, 2018."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kamo H, Ueno Y, Sugiyama M, et al. Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder. J Neuroimmunol 330: 19-22, 2019.","DOI":"10.1016\/j.jneuroim.2019.01.020"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kim SM, Kim JS, Heo YE, Yang HR, Park KS. Cortical oscillopsia without nystagmus, an isolated symptom of neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibody. Mult Scler 18: 244-247, 2012.","DOI":"10.1177\/1352458511414149"},{"key":"12","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.0b013e3181dc1af3","volume":"74","author":"A S\u00e1nchez-Carteyron","year":"2010","unstructured":"12. S\u00e1nchez-Carteyron A, Alarcia R, Ara JR, Mart\u00edn J. Posterior reversible encephalopathy syndrome after rituximab infusion in neuromyelitis optica. Neurology 74: 1471-1473, 2010.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Berger JR, Neltner J, Smith C, Cambi F. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica. Mult Scler Relat Disord 3: 728-731, 2014.","DOI":"10.1016\/j.msard.2014.08.004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Takeshita Y, Obermeier B, Cotleur AC, et al. Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro. Neurol Neuroimmunol Neuroinflamm 4: e311, 2016.","DOI":"10.1212\/NXI.0000000000000311"},{"key":"15","unstructured":"15. Shimizu F, Schaller KL, Owens GP, et al. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica. Sci Transl Med. Forthcoming."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Park JH, Hwang J, Min JH, Kim BJ, Kang ES, Lee KH. Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder. J Neurol Sci 348: 132-135, 2015.","DOI":"10.1016\/j.jns.2014.11.020"},{"key":"17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.44.5.899","volume":"44","author":"EL Alexander","year":"1994","unstructured":"17. Alexander EL, Ranzenbach MR, Kumar AJ, et al. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sj\u00f6gren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates. Neurology 44: 899-908, 1994.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jeong HN, Suh BC, Kim YB, Chung PW, Moon HS, Yoon WT. Posterior reversible encephalopathy syndrome as an initial neurological manifestation of primary Sj\u00f6gren's syndrome. Clin Auton Res 25: 259-262, 2015.","DOI":"10.1007\/s10286-015-0305-y"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/15\/59_4226-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T03:34:56Z","timestamp":1596252896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/15\/59_4226-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":18,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4226-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}